Future research directions could include prospective studies to better characterize the incidence, risk factors, and underlying mechanisms of ALK TKI-induced pneumonitis, along with the development of predictive biomarkers to identify patients at higher risk of developing pulmonary toxicity. The gene discussed is ALK; the disease is pneumonitis.